Larry A Allen1, G Michael Felker. 1. Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: Despite advancements in medical therapy, morbidity and mortality remain high. Surgical treatment of heart failure has been the subject of renewed focus, with a particular emphasis on applying the principles of evidence-based medicine to the evaluation of surgical therapies. The purpose of this review is to discuss emerging surgical therapies in heart failure, in particular, mechanical cardiac support and mitral valve repair. RECENT FINDINGS: The most widely established surgical therapy for heart failure is cardiac transplantation, but its impact is limited due to the limited number of donors. The Surgical Treatment for Ischemic Heart Failure study, a landmark evaluation of the role of coronary artery bypass grafting and surgical ventricular restoration in patients with ischemic heart disease and heart failure, has recently completed enrollment. Improvements in device design and patient selection appear likely to continue to improve outcomes with mechanical cardiac support in patients who are not deemed transplant candidates (destination therapy). Surgical repair of secondary mitral regurgitation is undergoing evaluation in the soon to be launched Surgery vs. Medical Treatment Alone for Patients with Mitral Regurgitation and Nonischemic study. SUMMARY: A variety of surgical therapies for heart failure are currently undergoing evaluation in randomized controlled trials. Data from these landmark studies will guide the application of surgical therapy in heart failure for the foreseeable future.
PURPOSE OF REVIEW: Despite advancements in medical therapy, morbidity and mortality remain high. Surgical treatment of heart failure has been the subject of renewed focus, with a particular emphasis on applying the principles of evidence-based medicine to the evaluation of surgical therapies. The purpose of this review is to discuss emerging surgical therapies in heart failure, in particular, mechanical cardiac support and mitral valve repair. RECENT FINDINGS: The most widely established surgical therapy for heart failure is cardiac transplantation, but its impact is limited due to the limited number of donors. The Surgical Treatment for Ischemic Heart Failure study, a landmark evaluation of the role of coronary artery bypass grafting and surgical ventricular restoration in patients with ischemic heart disease and heart failure, has recently completed enrollment. Improvements in device design and patient selection appear likely to continue to improve outcomes with mechanical cardiac support in patients who are not deemed transplant candidates (destination therapy). Surgical repair of secondary mitral regurgitation is undergoing evaluation in the soon to be launched Surgery vs. Medical Treatment Alone for Patients with Mitral Regurgitation and Nonischemic study. SUMMARY: A variety of surgical therapies for heart failure are currently undergoing evaluation in randomized controlled trials. Data from these landmark studies will guide the application of surgical therapy in heart failure for the foreseeable future.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Christopher H Cabell; Benjamin H Trichon; Eric J Velazquez; Jean G Dumesnil; Kevin J Anstrom; Thomas Ryan; Alan B Miller; Robert N Belkin; Anne B Cropp; Christopher M O'Connor; James G Jollis Journal: Am Heart J Date: 2004-01 Impact factor: 4.749
Authors: Ole A Breithardt; Anil M Sinha; Ehud Schwammenthal; Nadim Bidaoui; Kai U Markus; Andreas Franke; Christoph Stellbrink Journal: J Am Coll Cardiol Date: 2003-03-05 Impact factor: 24.094
Authors: Keith D Aaronson; Michael J Eppinger; David B Dyke; Susan Wright; Francis D Pagani Journal: J Am Coll Cardiol Date: 2002-04-17 Impact factor: 24.094
Authors: Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor Journal: Am J Cardiol Date: 2003-03-01 Impact factor: 2.778
Authors: Jonathan G Zaroff; Bruce R Rosengard; William F Armstrong; Wayne D Babcock; Anthony D'Alessandro; G William Dec; Niloo M Edwards; Robert S Higgins; Valluvan Jeevanandum; Myron Kauffman; James K Kirklin; Stephen R Large; Daniel Marelli; Tammie S Peterson; W Steves Ring; Robert C Robbins; Stuart D Russell; David O Taylor; Adrian Van Bakel; John Wallwork; James B Young Journal: Circulation Date: 2002-08-13 Impact factor: 29.690
Authors: Eric J Velazquez; Kerry L Lee; Christopher M O'Connor; Jae K Oh; Robert O Bonow; Gerald M Pohost; Arthur M Feldman; Daniel B Mark; Julio A Panza; George Sopko; Jean L Rouleau; Robert H Jones Journal: J Thorac Cardiovasc Surg Date: 2007-12 Impact factor: 5.209